Saxon Jill, Rah Marjorie J, Reindel William T
Vision Care, Bausch & Lomb Incorporated, Rochester, NY, USA,
Clin Optom (Auckl). 2019 Jan 9;11:1-10. doi: 10.2147/OPTO.S191835. eCollection 2019.
The purpose of this evaluation was to compare the experience of habitual contact lens wearers with that of nonwearers when fitted with a novel toric nesofilcon A contact lens (Biotrue ONEday for Astigmatism lens; Bausch & Lomb Incorporated, Rochester, NY, USA), for wearer comfort, vision, and satisfaction in a real-world setting.
Participating eye care practitioners (ECPs) prescribed toric nesofilcon A lenses to their astigmatic patients as part of their routine clinical practices. Accordingly, 1,253 patients successfully completed the evaluation; of these, 51% wore contact lenses habitually, 41% wore eyeglasses, and 8% had no prior vision correction. All wore the lenses for at least 4 days, and 74% wore them for an average of 9 hours or more per day. After at least 4 days of wear, each patient completed an online survey to evaluate his or her level of satisfaction regarding comfort and vision. As this postmarket evaluation was observational, data were analyzed to determine whether more patients than not agreed with individual statements regarding lens performance, and whether there was any difference in response between habitual contact lens wearers and nonwearers.
As a measure of general satisfaction, 96% of patients indicated that their overall opinion of the toric nesofilcon A lens was good to excellent. Further, more patients than not agreed that the lens performed well with regard to all aspects of vision and comfort queried (<0.001). There was no difference in response between habitual contact lens wearers and nonwearers.
All astigmatic patients with spherical contact lenses, other toric lenses, or eyeglasses, as well as those who had no prior correction, who had converted to the toric nesofilcon A lens expressed a high level of satisfaction with vision and comfort. ECPs should expect high success rates when converting astigmatic patients to the novel toric nesofilcon A lens.
本评估旨在比较习惯性佩戴隐形眼镜者与非佩戴者在佩戴新型复曲面奈索非康A隐形眼镜（博士伦散光日抛型隐形眼镜；美国纽约州罗切斯特市博士伦公司）时的体验，评估在实际使用环境中佩戴者的舒适度、视力及满意度。
参与研究的眼科保健从业者（ECP）在日常临床实践中为散光患者开具复曲面奈索非康A镜片。因此，1253名患者成功完成评估；其中，51%为习惯性佩戴隐形眼镜者，41%佩戴眼镜，8%既往无视力矫正史。所有患者佩戴镜片至少4天，74%的患者平均每天佩戴9小时或更长时间。佩戴至少4天后，每位患者完成一项在线调查，以评估其对舒适度和视力的满意程度。由于该上市后评估为观察性研究，因此对数据进行分析，以确定同意关于镜片性能的各项陈述的患者是否超过半数，以及习惯性隐形眼镜佩戴者与非佩戴者的回答是否存在差异。
作为总体满意度的衡量指标，96%的患者表示他们对复曲面奈索非康A镜片的总体评价为良好至优秀。此外，同意镜片在所有视力和舒适度方面表现良好的患者超过半数（<0.001）。习惯性隐形眼镜佩戴者与非佩戴者的回答没有差异。
所有由球面隐形眼镜、其他复曲面镜片或眼镜转换为复曲面奈索非康A镜片的散光患者，以及既往无矫正史的患者，对视力和舒适度都表示高度满意。眼科保健从业者在将散光患者转换为新型复曲面奈索非康A镜片时应预期会有较高的成功率。
